The U.S. Supreme Court upheld a lawsuit ruling against Medtronic that may cost the device manufacturer $200 million. The Supreme Court verified a lower court, which ruled the company infringed upon Edwards Lifesciences’ patent in a heart valve device.
Medtronic is facing additional legal trouble for its Infuse bone graft system, which has allegedly harmed many patients. The Medtronic Infuse is used to generate bone growth, but has been associated with serious side effects, including excessive bone growth, paralysis and retrograde ejaculation.
Medtronic allegedly promoted the bone graft device for use in unapproved methods, which may have attributed to the rise in Infuse side effects. According to recent research, the spinal complication rate associated with the Infuse bone graft device is 59%, almost 40% higher than alternative spinal bone graft procedures.